Last edition
News about "Bridge Biotherapeutics "
Bridge Biotherapeutics and HitGen to Advance Novel Cancer Therapeutics Program
Bridge plans to strengthen its existing oncology portfolio, which is centered on EGFR inhibitors for lung cancer treatment, through new anticancer drug candidates targeting undisclosed targets.
Bridge Biotherapeutics | 23/08/2024 | By Aishwarya | 143
Bridge Biotherapeutics New Venture into Immuno-Oncology with University of Colorado
Bridge Biotherapeutics has forged a research collaboration with Dr. Raul Torres's Lab at the University of Colorado School of Medicine.
Bridge Biotherapeutics | 27/03/2024 | By Manvi | 199
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy